About AstraZeneca PLC (AZN)
AstraZeneca PLC is a Drug Manufacturers - General company operating in the Healthcare sector.
AZN trades on the London Stock Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- £13,960.00
- Market Cap
- £216.51B
- 52-Week High
- £15,732.00
- 52-Week Low
- £9,892.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
£1,000 Invested in AstraZeneca PLC (AZN)
How much would £1,000 invested in AZN be worth today?
What would £1,000 invested in AZN 1 year ago be worth today?
A £1,000 investment in AstraZeneca PLC (AZN) in 2025 would be worth £1,129 as of November 2026, representing a +12.9% total return.
What would £1,000 invested in AZN 3 years ago be worth today?
A £1,000 investment in AstraZeneca PLC (AZN) in 2023 would be worth £1,359 as of November 2026, representing a +35.9% total return.
What would £1,000 invested in AZN 5 years ago be worth today?
A £1,000 investment in AstraZeneca PLC (AZN) in 2021 would be worth £1,496 as of November 2026, representing a +49.6% total return.
What would £1,000 invested in AZN 10 years ago be worth today?
A £1,000 investment in AstraZeneca PLC (AZN) in 2016 would be worth £3,060 as of November 2026, representing a +205.9% total return.
What would £1,000 invested in AZN at IPO be worth today?
A £1,000 investment in AstraZeneca PLC (AZN) at IPO would be worth £23,502 as of November 2026, representing a +2250.2% total return.
Monthly Returns Heatmap
Over the past 33+ years (401 months), AstraZeneca PLC (AZN) has averaged a monthly return of +0.99% with a median return of +0.47%. The stock had 216 positive months (54%) and 185 negative months (46%). The best month in AZN's history was October 2002 with a +23.7% return, while the worst was August 2002 at -20.4%. Historically, March tends to be the strongest month (averaging +2.7%), and February the weakest (-0.6%).
AZN's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2005 with a cumulative return of +42.1%, and the worst was 2004 at -33.2%.
Annual Returns
Over 33 years of trading history, AstraZeneca PLC (AZN) has delivered an average annual return of +10.79% with a median return of +4.74%. The compound annual growth rate (CAGR) is +9.00%. The stock posted gains in 22 years (67%) and losses in 11 years (33%).
AZN's best year was 2005 with a +49.80% gain, while the worst was 2004 at -29.50%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. AZN achieved double-digit gains (10%+) in 16 years. It suffered double-digit losses in 3 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +1.25% | £13,787.67 | £13,960.00 |
| 2025 | +31.76% | £10,464.01 | £13,787.67 |
| 2024 | -1.22% | £10,593.67 | £10,464.01 |
| 2023 | -5.49% | £11,209.00 | £10,593.67 |
| 2022 | +29.30% | £8,669.02 | £11,209.00 |
| 2021 | +18.52% | £7,314.43 | £8,669.02 |
| 2020 | -3.69% | £7,594.96 | £7,314.43 |
| 2019 | +29.57% | £5,861.74 | £7,594.96 |
| 2018 | +14.73% | £5,109.18 | £5,861.74 |
| 2017 | +15.46% | £4,425.16 | £5,109.18 |
| 2016 | -3.83% | £4,601.49 | £4,425.16 |
| 2015 | +1.39% | £4,538.60 | £4,601.49 |
| 2014 | +27.50% | £3,559.77 | £4,538.60 |
| 2013 | +22.93% | £2,895.83 | £3,559.77 |
| 2012 | -2.14% | £2,959.26 | £2,895.83 |
| 2011 | +1.87% | £2,904.90 | £2,959.26 |
| 2010 | +0.44% | £2,892.03 | £2,904.90 |
| 2009 | +3.74% | £2,787.77 | £2,892.03 |
| 2008 | +29.77% | £2,148.24 | £2,787.77 |
| 2007 | -21.11% | £2,723.16 | £2,148.24 |
| 2006 | -2.98% | £2,806.74 | £2,723.16 |
| 2005 | +49.80% | £1,873.67 | £2,806.74 |
| 2004 | -29.50% | £2,657.78 | £1,873.67 |
| 2003 | +20.74% | £2,201.17 | £2,657.78 |
| 2002 | -28.33% | £3,071.20 | £2,201.17 |
| 2001 | -8.19% | £3,345.27 | £3,071.20 |
| 2000 | +34.71% | £2,483.24 | £3,345.27 |
| 1999 | -1.82% | £2,529.26 | £2,483.24 |
| 1998 | +22.48% | £2,065.02 | £2,529.26 |
| 1997 | +29.74% | £1,591.69 | £2,065.02 |
| 1996 | +32.25% | £1,203.52 | £1,591.69 |
| 1995 | +41.58% | £850.05 | £1,203.52 |
| 1994 | +4.74% | £811.60 | £850.05 |
Frequently Asked Questions: AZN
What sector is AZN in? ▼
AZN operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has AZN performed historically? ▼
Over 33 years of trading history, AZN has posted gains in 22 years (67% of the time). The best year was 2005 with a +49.8% return. Past performance does not guarantee future results.
How can I invest in AZN? ▼
You can invest in AZN through any brokerage account that offers access to the London Stock Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold AZN.
Last updated: 11/1/2026